Literature DB >> 3501736

The case for global eradication of poliomyelitis.

A R Hinman, W H Foege, C A de Quadros, P A Patriarca, W A Orenstein, E W Brink.   

Abstract

Global eradication of poliomyelitis can be achieved by a programme strategy that includes achievement and maintenance of high immunization levels, effective surveillance to detect all new cases, and a rapid vigorous response to the occurrence of new cases. Regional eradication targets have already been set in Europe and the Americas. Possible impediments to eradication include the necessity to generate political and social will; managerial constraints; issues of vaccine efficacy, stability, and cost; and adequacy of surveillance. We believe that the impediments can be overcome and that with intensified effort and increased international collaboration, global eradication could be achieved as early as 1995.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3501736      PMCID: PMC2491079     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  3 in total

1.  Serological comparisons of approaches to polio vaccination in the Gambia.

Authors:  P Hanlon; L Hanlon; V Marsh; P Byass; H Sillah; R Hayes; H C Whittle; B M Greenwood
Journal:  Lancet       Date:  1987-04-04       Impact factor: 79.321

2.  Eradication of poliomyelitis in the United States.

Authors:  N Nathanson
Journal:  Rev Infect Dis       Date:  1982 Sep-Oct

3.  Outbreak of paralytic poliomyelitis, Taiwan.

Authors:  R J Kim-Farley; G Rutherford; P Lichfield; S T Hsu; W A Orenstein; L B Schonberger; K J Bart; K J Lui; C C Lin
Journal:  Lancet       Date:  1984-12-08       Impact factor: 79.321

  3 in total
  9 in total

1.  1889 to 1989: a century of health and disease.

Authors:  A R Hinman
Journal:  Public Health Rep       Date:  1990 Jul-Aug       Impact factor: 2.792

2.  A ten-year experience in control of poliomyelitis through a combination of live and killed vaccines in two developing areas.

Authors:  T Tulchinsky; Y Abed; S Shaheen; N Toubassi; Y Sever; M Schoenbaum; R Handsher
Journal:  Am J Public Health       Date:  1989-12       Impact factor: 9.308

3.  Global eradication of poliomyelitis: benefit-cost analysis.

Authors:  K J Bart; J Foulds; P Patriarca
Journal:  Bull World Health Organ       Date:  1996       Impact factor: 9.408

Review 4.  Perspectives on rapid elimination and ultimate global eradication of paralytic poliomyelitis caused by polioviruses.

Authors:  A B Sabin
Journal:  Eur J Epidemiol       Date:  1991-03       Impact factor: 8.082

5.  Immunizing the children of the world: progress and prospects.

Authors:  R H Henderson; J Keja; G Hayden; A Galazka; J Clements; C Chan
Journal:  Bull World Health Organ       Date:  1988       Impact factor: 9.408

6.  A new epidemiologic and laboratory classification system for paralytic poliomyelitis cases.

Authors:  R W Sutter; E W Brink; S L Cochi; O M Kew; W A Orenstein; R J Biellik; A R Hinman
Journal:  Am J Public Health       Date:  1989-04       Impact factor: 9.308

Review 7.  Quest for life-long protection by vaccination.

Authors:  W R Dowdle; W A Orenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

Review 8.  Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge.

Authors:  Thomas R Hird; Nicholas C Grassly
Journal:  PLoS Pathog       Date:  2012-04-19       Impact factor: 6.823

9.  The path towards polio eradication over 40 years of the Expanded Program on Immunization in the Americas.

Authors:  Cristina Pedreira; Elizabeth Thrush; Gloria Rey-Benito; Ana Elena Chévez; Barbara Jauregui
Journal:  Rev Panam Salud Publica       Date:  2017-12-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.